Thermo Fisher Scientific Inc. (TSX:TMO)

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Life Sciences Solutions Revenue	10.99B	10.37B	9.63B
Analytical Instruments Revenue	7.67B	7.55B	7.46B
Specialty Diagnostics Revenue	4.74B	4.68B	4.51B
Laboratory Products and Biopharma Services Revenue	25.08B	23.98B	23.16B
Revenue (Other)	-2.14B	-2.03B	-1.88B
Revenue (Total)	46.34B	44.56B	42.88B

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Consumables Revenue	19.50B	18.66B	17.59B
Instruments Revenue	7.34B	7.30B	7.45B
Services Revenue	19.50B	18.59B	17.85B
Revenue (Total)	46.34B	44.56B	42.88B

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
North America Revenue	23.65B	23.03B	22.50B
Europe Revenue	12.64B	11.83B	10.86B
Asia-Pacific Revenue	8.36B	8.10B	7.96B
Other Regions Revenue	1.68B	1.60B	1.56B
Revenue (Other)	1.00M	-1.00M	1.00M
Revenue (Total)	46.34B	44.56B	42.88B

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Life Sciences Solutions Operating Income	4.01B	3.77B	3.50B
Analytical Instruments Operating Income	1.79B	1.74B	1.96B
Specialty Diagnostics Operating Income	1.29B	1.26B	1.16B
Laboratory Products and Biopharma Services Operating Income	3.51B	3.35B	3.09B
Operating Income (Other)	-2.45B	-2.36B	-2.37B
Operating Income (Total)	8.15B	7.75B	7.34B

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Total Organic Revenue Growth	2.00%	-

Data Source: Fiscal.ai Last updated: Jun 27, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 18, 2026

Data Sources Report a data error